Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 18151-18200 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT03164057
A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia
PHASE2
Active, not recruiting
206 participants
Started: Jun 15, 2017 · Completed: Jun 30, 2027
2 conditions
1 sponsor
10 locations
NCT03158454
Capsula Closure vs. Non-Capsula Closure: Hip Arthroscopy in Danish Patients With Femoroacetabular Impingement (FAI)
NA
Active, not recruiting
200 participants
Started: Jun 15, 2017 · Completed: Dec 1, 2028
1 condition
1 sponsor
1 location
NCT03001830
Gene Therapy for Haemophilia A.
PHASE1/PHASE2
Active, not recruiting
14 participants
Started: Jun 14, 2017 · Completed: Dec 31, 2029
1 condition
2 sponsors
4 locations
NCT02945566
Can We Save the Rectum by Watchful Waiting or TransAnal Surgery Following (chemo)Radiotherapy Versus Total Mesorectal Excision for Early REctal Cancer?
PHASE2/PHASE3
Active, not recruiting
380 participants
Started: Jun 14, 2017 · Completed: Aug 31, 2028
1 condition
1 sponsor
5 locations
NCT03535818
Adjunctive Ganglionated Plexus Ablation in Redo-Pulmonary Vein Isolation
NA
Active, not recruiting
68 participants
Started: Jun 14, 2017 · Completed: Feb 1, 2026
2 conditions
1 sponsor
1 location
NCT03125928
Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast Cancer
PHASE2
Active, not recruiting
16 participants
Started: Jun 13, 2017 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT03187951
PancFit: Multimodal Exercise During Preoperative Therapy for Pancreatic Cancer
NA
Active, not recruiting
152 participants
Started: Jun 13, 2017 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT03503864
Phase II Study of Combined Chemotherapy With Arsenic Trioxide in Stage 4/M Neuroblastoma
PHASE2
Active, not recruiting
80 participants
Started: Jun 12, 2017 · Completed: Dec 30, 2028
1 condition
1 sponsor
1 location
NCT03172754
Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma
PHASE1/PHASE2
Active, not recruiting
98 participants
Started: Jun 12, 2017 · Completed: Oct 6, 2025
1 condition
1 sponsor
4 locations
NCT02774421
Pilot Study of the Effect of Trastuzumab and GM-CSF on Children with Recurrent Ependymoma
PHASE1
Active, not recruiting
33 participants
Started: Jun 12, 2017 · Completed: Mar 31, 2026
1 condition
2 sponsors
1 location
NCT03028857
Choline Supplementation During Pregnancy: Impact on Attention and Social Withdrawal
PHASE1
Active, not recruiting
600 participants
Started: Jun 12, 2017 · Completed: Dec 31, 2026
2 conditions
1 sponsor
2 locations
NCT03189706
Study of Chemoimmunotherapy for High-Risk Neuroblastoma
EARLY_PHASE1
Active, not recruiting
48 participants
Started: Jun 12, 2017 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
NCT03810612
Patient-reported Outcomes After Percutaneous Coronary Intervention
N/A
Active, not recruiting
3,417 participants
Started: Jun 12, 2017 · Completed: May 31, 2030
1 condition
8 sponsors
7 locations
NCT03142334
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)
PHASE3
Active, not recruiting
994 participants
Started: Jun 9, 2017 · Completed: Dec 28, 2025
1 condition
1 sponsor
251 locations
NCT03179917
Pembrolizumab and Involved Site Radiation Therapy for Early Stage Relapsed or Primary Refractory Hodgkin Lymphoma
PHASE2
Active, not recruiting
22 participants
Started: Jun 8, 2017 · Completed: Jun 30, 2026
1 condition
1 sponsor
9 locations
NCT02962414
Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment
PHASE3
Active, not recruiting
206 participants
Started: Jun 8, 2017 · Completed: Aug 13, 2027
1 condition
1 sponsor
68 locations
NCT02808208
Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure
PHASE1/PHASE2
Active, not recruiting
74 participants
Started: Jun 7, 2017 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT03179930
Combination Therapy With Entinostat and Pembrolizumab in Relapsed and Refractory Lymphomas
PHASE2
Active, not recruiting
47 participants
Started: Jun 7, 2017 · Completed: Jun 30, 2026
3 conditions
3 sponsors
9 locations
NCT03818620
Research in the Development of a New Type of Digital Dermatoscope for Skin Cancer
N/A
Active, not recruiting
3,000 participants
Started: Jun 7, 2017 · Completed: Apr 30, 2025
2 conditions
1 sponsor
2 locations
NCT03233594
PET Imaging of Chronic Pain Syndromes
N/A
Active, not recruiting
32 participants
Started: Jun 7, 2017 · Completed: Apr 1, 2026
1 condition
1 sponsor
2 locations
NCT06809127
Brain Plasticity and Emotion Recognition in Patients With Facial Palsy Before & After Surgical Rehabilitation: MEG Study
NA
Active, not recruiting
29 participants
Started: Jun 6, 2017 · Completed: Jun 26, 2026
2 conditions
2 sponsors
1 location
NCT03114072
Blocking Blue Light in Pregnancy, Effects on Melatonin Profile and Sleep
NA
Active, not recruiting
60 participants
Started: Jun 6, 2017 · Completed: Jul 31, 2026
1 condition
3 sponsors
1 location
NCT03173924
18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer
PHASE2
Active, not recruiting
96 participants
Started: Jun 6, 2017 · Completed: Feb 6, 2028
5 conditions
1 sponsor
1 location
NCT06337955
Non Primary HCMV Infection: Natural History and Immune Response
N/A
Active, not recruiting
204 participants
Started: Jun 6, 2017 · Completed: Dec 31, 2024
1 condition
4 sponsors
1 location
NCT03044392
"Determination of the Optimal Next Bolus Interval for Programmed Intermittent Bolus Epidural Analgesia"
NA
Active, not recruiting
84 participants
Started: Jun 5, 2017 · Completed: Jul 1, 2024
1 condition
1 sponsor
1 location
NCT03021486
Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer
PHASE2/PHASE3
Active, not recruiting
70 participants
Started: Jun 5, 2017 · Completed: Jun 30, 2027
5 conditions
4 sponsors
1 location
NCT03153319
Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VI
PHASE1/PHASE2
Active, not recruiting
14 participants
Started: Jun 5, 2017 · Completed: Jun 30, 2026
3 conditions
2 sponsors
1 location
NCT03057626
Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma
N/A
Active, not recruiting
376 participants
Started: Jun 5, 2017 · Completed: Sep 30, 2025
6 conditions
2 sponsors
98 locations
NCT03022825
QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer
PHASE2/PHASE3
Active, not recruiting
190 participants
Started: Jun 2, 2017 · Completed: Mar 1, 2029
1 condition
1 sponsor
28 locations
NCT02706353
APX005M in Combination With Systemic Pembrolizumab in Patients With Metastatic Melanoma
PHASE1/PHASE2
Active, not recruiting
32 participants
Started: Jun 2, 2017 · Completed: Apr 30, 2025
1 condition
3 sponsors
1 location
NCT03157323
Low GI Diet in Children and Adolescents With ALL
NA
Active, not recruiting
88 participants
Started: Jun 1, 2017 · Completed: Jun 30, 2026
2 conditions
3 sponsors
5 locations
NCT03088033
REDUCE LAP-HF TRIAL II
NA
Active, not recruiting
608 participants
Started: Jun 1, 2017 · Completed: Sep 30, 2026
1 condition
1 sponsor
91 locations
NCT03561805
Prolonged Continuous ECG Monitoring Prior to Transcatheter Aortic Valve Implantation
NA
Active, not recruiting
106 participants
Started: Jun 1, 2017 · Completed: Jun 1, 2026
2 conditions
1 sponsor
1 location
NCT03164616
Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).
PHASE3
Active, not recruiting
1,186 participants
Started: Jun 1, 2017 · Completed: Nov 15, 2027
1 condition
1 sponsor
175 locations
NCT03089268
Molecular and Histological Characteristics of Serrated Lesions of the Colon
N/A
Active, not recruiting
700 participants
Started: Jun 1, 2017 · Completed: Jan 1, 2028
4 conditions
1 sponsor
1 location
NCT03343184
Clinical Evaluation of Bulk Fill Composite Restorations Associated to Universal Adhesive System
NA
Active, not recruiting
50 participants
Started: Jun 1, 2017 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT03504059
School-based Behavioural Intervention to Face Obesity and Promote Cardiovascular Health Among Spanish Adolescents
NA
Active, not recruiting
1,326 participants
Started: Jun 1, 2017 · Completed: Jun 30, 2025
3 conditions
5 sponsors
3 locations
NCT02992782
Decongestive Exercise and Compression for Breast Cancer Related Lymphedema Management
NA
Active, not recruiting
60 participants
Started: Jun 1, 2017 · Completed: Aug 28, 2025
2 conditions
2 sponsors
1 location
NCT03133208
Sepsis Associated Encephalopathy (SAE) Biomarkers
N/A
Active, not recruiting
90 participants
Started: Jun 1, 2017 · Completed: Jul 6, 2025
5 conditions
1 sponsor
1 location
NCT02758951
Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases
PHASE2/PHASE3
Active, not recruiting
358 participants
Started: Jun 1, 2017 · Completed: Jun 1, 2029
11 conditions
4 sponsors
9 locations
NCT03216733
SORT OUT X - Combo Stent Versus ORSIRO Stent
NA
Active, not recruiting
3,148 participants
Started: Jun 1, 2017 · Completed: Dec 31, 2028
3 conditions
3 sponsors
4 locations
NCT03155191
Study of TBI-1501 for Relapsed or Refractory Acute Lymphoblastic Leukemia
PHASE1/PHASE2
Active, not recruiting
21 participants
Started: Jun 1, 2017 · Completed: Mar 31, 2035
1 condition
1 sponsor
11 locations
NCT02661997
Novel Interventions for GWVI
NA
Active, not recruiting
114 participants
Started: Jun 1, 2017 · Completed: Sep 30, 2025
1 condition
3 sponsors
1 location
NCT03623464
RCT of Mobile Apps & FitBit v. Usual Care
NA
Active, not recruiting
107 participants
Started: May 31, 2017 · Completed: Aug 31, 2025
6 conditions
2 sponsors
1 location
NCT03170206
Study of Palbociclib in Combination With Binimetinib for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer
PHASE1
Active, not recruiting
34 participants
Started: May 31, 2017 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT03050931
Electrical Impedance Tomography of Epilepsy
N/A
Active, not recruiting
42 participants
Started: May 30, 2017 · Completed: Dec 31, 2027
1 condition
2 sponsors
1 location
NCT03153475
ATTUNE Revision System in the Revision Total Knee Arthroplasty Population
NA
Active, not recruiting
400 participants
Started: May 30, 2017 · Completed: Mar 31, 2029
1 condition
1 sponsor
38 locations
NCT02926690
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
PHASE1
Active, not recruiting
70 participants
Started: May 29, 2017 · Completed: Sep 30, 2027
1 condition
1 sponsor
5 locations
NCT03113500
Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma
PHASE2
Active, not recruiting
48 participants
Started: May 25, 2017 · Completed: Aug 12, 2025
11 conditions
2 sponsors
5 locations
NCT02955082
The BARCODE 2 Study - The Use of Genetic Profiling to Guide Prostate Cancer Treatment
PHASE2
Active, not recruiting
305 participants
Started: May 25, 2017 · Completed: Sep 30, 2025
1 condition
13 sponsors
1 location
Previous
1
More pages
361
362
363
364
365
366
367
More pages
431
Next